Displaying all 7 publications

Abstract:
Sort:
  1. Fulltext Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
    Kow CS, Zaihan AF, Hasan SS
    J Stroke Cerebrovasc Dis, 2020 12;29(12):105222.
    PMID: 32891494 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105222
  2. Has it come to the time to recommend routine use of alirocumab in patients with acute coronary syndrome?
    Kow CS, Zaihan AF, Hasan SS
    Eur J Prev Cardiol, 2020 Dec 28.
    PMID: 33624099 DOI: 10.1093/eurjpc/zwaa148
  3. Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?
    Kow CS, Zaihan AF, Hasan SS
    Eur Heart J, 2021 07 08;42(26):2609-2610.
    PMID: 33205147 DOI: 10.1093/eurheartj/ehaa880
  4. CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke
    Kow CS, Zaihan AF, Hasan SS
    Clin Drug Investig, 2021 01;41(1):115-116.
    PMID: 33237558 DOI: 10.1007/s40261-020-00985-5
  5. The Potential of SGLT2 Inhibitors to Counteract Anemia in Patients with Heart Failure
    Kow CS, Zaihan AF, Thiruchelvam K
    J Gen Intern Med, 2024 Nov 07.
    PMID: 39511119 DOI: 10.1007/s11606-024-09096-9
  6. Fulltext IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?
    Kow CS, Zaihan AF, Ramachandram DS, Hasan SS
    Cytokine, 2022 Jan;149:155730.
    PMID: 34628129 DOI: 10.1016/j.cyto.2021.155730
  7. Comment on: "Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study"
    Kow CS, Zaihan AF, Ramachandram DS, Hasan SS
    Am J Cardiovasc Drugs, 2024 Mar;24(2):325-326.
    PMID: 38270840 DOI: 10.1007/s40256-023-00626-0
Related Terms
Filters
Contact Us

Please provide feedback to Administrator ([email protected])

External Links